ATAI Life Sciences
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $1,704 | $953 | $1,066 | $749 |
Gross Profit | 1,489 | 787 | 1,066 | 516 |
EBITDA | -43,926 | -29,615 | -544,920 | -60,763 |
EBIT | -44,141 | -29,782 | -544,922 | -60,996 |
Net Income | -32,524 | -29,781 | -544,813 | -61,074 |
Net Change In Cash | 1,704 | 953 | 1,066 | 749 |
Free Cash Flow | -35,273 | -21,090 | -48,253 | -28,624 |
Cash | 168,807 | 43,102 | 85,300 | 30,402 |
Basic Shares | 360,753 | 357,421 | 222,067 | 217,601 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $4,089 | $308 | $314 | $233 |
Gross Profit | 3,077 | -165 | -5 | 65 |
EBITDA | -657,675 | -147,333 | -39,904 | -150,097 |
EBIT | -658,687 | -147,806 | -40,223 | -150,265 |
Net Income | -660,047 | -149,269 | -40,224 | -152,385 |
Net Change In Cash | 4,089 | 308 | 314 | 233 |
Cost of Revenue | -170,530 | |||
Free Cash Flow | -103,576 | -82,532 | -84,708 | -105,491 |
Cash | 85,300 | 17,505 | 45,034 | 190,613 |
Basic Shares | 226,532 | 160,159 | 158,833 | 155,719 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.09 |
2026-03-31 | -$0.08 |
2025-12-31 | -$1.73 |
2025-09-30 | -$0.28 |